Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 48 (3), 201-210
- https://doi.org/10.1016/s0168-8227(00)00122-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical evidence: Glycaemic control in diabetesBMJ, 1999
- Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Economic Consequences of Diabetes Mellitus in the U.S. in 1997Diabetes Care, 1998
- Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research GroupJAMA, 1996
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.BMJ, 1992
- Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studiesDiabetologia, 1991
- Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study GroupPublished by American Medical Association (AMA) ,1988